DUBLIN, Sept. 11, 2019 /PRNewswire/ -- The "In-Vitro Diagnostics Global Market Forecast To 2022" report has been added to ResearchAndMarkets.com's offering.
Global In-Vitro Diagnostics Market Forecast to 2022 provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market.
The in-vitro diagnostics devices (or) equipment manufacturing market consists of sales of in-vitro diagnostic equipment and related services by entities (organizations, sole traders and partnerships) that produce in-vitro diagnostics. This industry includes establishments that produce diagnostic devices used in microbiological diagnosis, hematological diagnosis, molecular diagnosis, point of care diagnosis and others.
Where is the largest and fastest growing market for the in-vitro diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-Vitro Diagnostics market global report from the author answers all these questions and many more.
North America was the largest region in the global in-vitro diagnostics market, accounting for 35% of the market in 2018. Asia Pacific was the second largest region accounting for 34% of the global in-vitro diagnostics market. Africa was the smallest region in the global in-vitro diagnostics market.
Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature's expertise in both next-generation sequencing (NGS) assays and biobanks.
In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space.
Key Topics Covered:
1. Executive Summary
2. Report Structure
3. In-Vitro Diagnostics Market Characteristics
3.1. Market Definition
3.2. Key Segmentations
4. In-Vitro Diagnostics Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products
5. In-Vitro Diagnostics Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers
6. In-Vitro Diagnostics Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth
7. In-Vitro Diagnostics Market Trends And Strategies
8. In-Vitro Diagnostics Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market
9. In-Vitro Diagnostics Market Regional Analysis
9.1. Global In-Vitro Diagnostics Market, 2018, By Region, Value ($ Billion)
9.2. Global In-Vitro Diagnostics Market, 2014 - 2022, Historic And Forecast, By Region
9.3. Global In-Vitro Diagnostics Market, Growth And Market Share Comparison, By Region
10. In-Vitro Diagnostics Market Segmentation
10.1. Global In-Vitro Diagnostics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
10.1.1. Point-of-Care Diagnostics
10.1.2. Immunochemistry
10.1.3. Clinical Chemistry Diagnostics Devices
10.1.4. Molecular Diagnostics
10.1.5. Microbiology
10.1.6. Hemostasis
10.1.7. Hematology
10.1.8. Immunohematology
11. In-Vitro Diagnostics Market Segments
11.1. Global Point-of-Care Diagnostics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.2. Global Immunochemistry Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.3. Global Clinical Chemistry Diagnostics Devices Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.4. Global Molecular Diagnostics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.5. Global Microbiology Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.6. Global Hemostasis Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.7. Global Hematology Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
11.8. Global Immunohematology Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
12. In-Vitro Diagnostics Market Metrics
12.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, 2014 - 2022, Global
12.2. Per Capita Average In-Vitro Diagnostics Market Expenditure, 2014 - 2022, Global
Companies Mentioned
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Danaher (Beckman Coulter Inc)
- Abbott Laboratories Inc
- Thermo Fisher Scientific Inc
For more information about this report visit https://www.researchandmarkets.com/r/v2i5a8
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article